FDA to allow retail pharmacies to offer abortion pills
Abigail Adcox
Video Embed
The Food and Drug Administration will allow retail pharmacies to dispense abortion medication to women who have a prescription for the first time.
Under the new regulatory change, pharmacies that become certified can offer mifepristone, which is used with misoprostol to end pregnancy, to patients who have received a prescription from a qualified health provider, a move that will expand access to the medication. Previously, the FDA had only allowed abortion medication to be prescribed and dispensed only by clinics, medical offices, hospitals, or under the supervision of a certified health provider.
HOUSE DEMS FAULT FDA’S ‘ATYPICAL’ REVIEW PROCESS FOR BIOGEN’S ALZHEIMER’S DRUG
“Today’s FDA announcement expands access to medications that are essential for reproductive autonomy and is a step in the right direction that is especially needed to increase access to abortion care,” said Evan Masingill, the CEO of GenBioPro, the manufacturer of generic mifepristone, in a statement to the Washington Examiner. “GenBioPro looks forward to working with prescribers and pharmacies to increase access to medical abortion care for all people.”
CLICK HERE TO READ MORE FROM THE WASHINGTON EXAMINER
The FDA had previously said in December 2021 that it would no longer enforce a rule that required people to get the first of the two drugs in person at a medical office or clinic, allowing abortion medication to be sent through the mail during the COVID-19 pandemic.